U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. Reports, Manuals, & Forms
  4. Reports
  5. Economic Impact Analyses of FDA Regulations
  6. Revocation of Authorization for Use of Brominated Vegetable Oil in Food (Final Rule)
  1. Economic Impact Analyses of FDA Regulations

Revocation of Authorization for Use of Brominated Vegetable Oil in Food (Final Rule)

The final rule will remove the authorization for the use of brominated vegetable oil (BVO) in food. Specifically, the final rule will remove 21 CFR 180.30. We are taking this action because there is no longer a basis to conclude that this use is safe. BVO is a complex mixture of plant-derived triglycerides that have been reacted to contain atoms of the element bromine bonded to the molecules.  BVO is used primarily to help emulsify citrus-flavored soft drinks, preventing them from separating during distribution.

We quantify benefits in terms of reduction in BVO exposure under the final rule relative to the baseline exposure associated with gradual voluntary reduction of BVO. Although studies suggest that excessive consumption of BVO may cause adverse events such endocrine and central nervous systems disruptions, and that bromine also accumulates easily in the body, clinical data on adverse events in humans from consuming BVO are limited and there is a lack of published independent studies that estimate the change in health outcomes from removing BVO from the food industry. Because of the data limitations and absence of independent studies that quantify health benefits, we do not estimate the monetary value of the public health benefits of this final rule. We quantify the costs to industry of reformulating and re-labeling products currently manufactured with BVO relative to the baseline cost of gradual voluntary reduction of BVO. Because established alternatives to BVO already exist, and many manufacturers have already reformulated their products to replace BVO, we assume that there will be a minimal change to product properties. We estimate that the annualized reduction in BVO exposure over 20 years under the final rule relative to the baseline of gradual voluntary reduction will range from 0.01 to 0.03 million ounces (oz), with a primary estimate of 0.02 million oz. The annualized costs relative to the baseline of gradual voluntary reduction of BVO will range from $0.02 million and $0.06 million at a 2 percent discount rate, with a primary estimate of $0.04 million.

Regulatory Impact Analysis

Revocation of Authorization for Use of Brominated Vegetable Oil in Food (Final Rule) (PDF 512 KB)

Federal Register: 89 FR 55040
Publication Date: 07/03/2024 Docket number: FDA-2023-N-0937

 

Back to Top